Results for
""Formoterol Fumarate""[mesh_terms]

Asthma Management Considerations for the Otolaryngologist: Current Therapies.

Dhanya Asokumar, Amarbir S Gill

Otolaryngologic clinics of North America 2024;57(2):215-224

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Artur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, Mihir Shah, Ibrahim Raphiou, David Petullo, John Xu, Maria Heijer, Klementyna Sychowicz, Kathryn Collison, Carlos Silva, Jitendar Reddy, David Han, Ronald Goldwater, Michael Gillen, Mehul Patel

Therapeutic advances in respiratory disease 2026;20():17534666261417149

Assay validation for vilanterol and its metabolites in human urine with application for doping control analysis.

Tina Panchal, Sandra Baldwin, Martin Østergaard, Erik Soeren Halvard Hansen, Vibeke Backer, Morten Hostrup, Peter Daley-Yates

Drug testing and analysis 2023;15(5):495-505

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.

David B Price, Vicky Thomas, P N Richard Dekhuijzen, Sinthia Bosnic-Anticevich, Nicolas Roche, Federico Lavorini, Priyanka Raju, Daryl Freeman, Carole Nicholls, Iain R Small, Erika Sims, Guilherme Safioti, Janice Canvin, Henry Chrystyn

BMC pulmonary medicine 2019;18(1):107

Beta-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men.

Johan Onslev, Glenn Jacobson, Christian Narkowicz, Vibeke Backer, Anders Kalsen, Michael Kreiberg, Søren Jessen, Jens Bangsbo, Morten Hostrup

European journal of applied physiology 2018;117(9):1907-1915

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD.

Simon Wan Yau Ming, John Haughney, Dermot Ryan, Iain Small, Federico Lavorini, Alberto Papi, Dave Singh, David M G Halpin, John R Hurst, Shishir Patel, Matthias Ochel, Janwillem Kocks, Victoria Carter, Antony Hardjojo, David B Price

International journal of chronic obstructive pulmonary disease 2021;15():3093-3103

NMR-Based Metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease Patients.

Alessia Vignoli, Giuseppe Santini, Leonardo Tenori, Giuseppe Macis, Nadia Mores, Francesco Macagno, Francesco Pagano, Tim Higenbottam, Claudio Luchinat, Paolo Montuschi

Journal of proteome research 2021;19(1):64-74

Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.

Jean Bousquet, Gianluigi Poli, Daniela Acerbi, Raffaella Monno, Steven Ramael, Fabrice Nollevaux

Clinical pharmacokinetics 2010;48(6):347-58

Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.

Rikke Kaae, Lone Agertoft, Sören Pedersen, S Lennart Nordvall, Christophe Pedroletti, Thomas Bengtsson, Ingegerd Johannes-Hellberg, Johan Rosenborg

British journal of clinical pharmacology 2005;58(4):411-8

Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study.

Jaco Voorham, Simonetta Baldi, Luigi Santoro, Marjan Kerkhof, Marco Contoli, Leonardo M Fabbri, Huib A M Kerstjens, Jose Luis López-Campos, Nicolas Roche, Dave Singh, Claus F Vogelmeier, David B Price

International journal of chronic obstructive pulmonary disease 2021;15():2739-2750

Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.

Tomoko Hasunuma, Takefumi Saito

Clinical drug investigation 2012;32(1):51-61

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma.

Emma J Welsh, Christopher J Cates

The Cochrane database of systematic reviews 2010;2010(9):CD008418

Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients.

J Rosenborg, R Larsson, Z Rott, C Böcskei, M Poczi, G Juhász

Respiratory medicine 2002;96(6):412-7

Formoterol, a highly β2-selective agonist, induces gender-dimorphic whole body leucine metabolism in humans.

Paul Lee, Vita Birzniece, A Margot Umpleby, Anne Poljak, Ken K Y Ho

Metabolism: clinical and experimental 2015;64(4):506-12